Dagli Mandeep, Ramchandani Parvati
University of Pennsylvania Medical Center, Philadelphia, Pennsylvania.
Semin Intervent Radiol. 2011 Dec;28(4):424-37. doi: 10.1055/s-0031-1296085.
First described in 1955 by Goodwin et al as a minimally invasive treatment for urinary obstruction causing marked hydronephrosis, percutaneous nephrostomy (PCN) placement quickly found use in a wide variety of clinical indications in both dilated and nondilated systems. Although the advancement of modern endourological techniques has led to a decline in the indications for primary nephrostomy placement, PCNs still play an important role in the treatment of multiple urologic conditions. In this article, the indications, placement, and postprocedure management of percutaneous nephrostomy drainage are described.
经皮肾造瘘术(PCN)于1955年由古德温等人首次描述为一种治疗导致明显肾积水的尿路梗阻的微创治疗方法,很快就在扩张和未扩张系统的各种临床适应症中得到应用。尽管现代腔内泌尿外科技术的进步导致了原发性肾造瘘术放置适应症的减少,但经皮肾造瘘术在多种泌尿外科疾病的治疗中仍发挥着重要作用。本文描述了经皮肾造瘘引流的适应症、放置方法及术后管理。